Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$75.66M
↑ 378% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
$-27.25M
Historical baseline
PeriodValueYoY Change
2025$75.66M+140.4%
2024$31.47M+648.0%
2023$-5.74M+92.2%
2022$-73.76M-1354.8%
2021$5.88M+111.3%
2020$-52.19M-25.7%
2019$-41.51M+29.4%
2018$-58.83M+24.2%
2017$-77.56M-2.2%
2016$-75.89M-